Michael Kaswan

Insider Reports History

Location
New York, NY
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Kaswan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Orchestra BioMed Holdings, Inc. Chief Financial Officer Common Stock, par value $0.0001 per share ("Common Stock") 162,574 $175,580 $1.08 12 Apr 2023 Direct
Orchestra BioMed Holdings, Inc. Chief Financial Officer Nonstatutory Stock Option (Right to Buy) 192,566 26 Jan 2023 Direct
Orchestra BioMed Holdings, Inc. Chief Financial Officer Right to Receive Earnout Shares 29,029 12 Apr 2023 Direct

Insider Reports Filed by Michael Kaswan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OBIO Orchestra BioMed Holdings, Inc. 12 Apr 2023 2 $0 4 Chief Financial Officer 05 May 2023, 20:17
OBIO Orchestra BioMed Holdings, Inc. 26 Jan 2023 1 $0 4/A Chief Financial Officer 19 May 2023, 17:55
OBIO Orchestra BioMed Holdings, Inc. 26 Jan 2023 1 $0 4/A Chief Financial Officer 05 May 2023, 20:10
OBIO Orchestra BioMed Holdings, Inc. 26 Jan 2023 0 $0 3 Chief Financial Officer 30 Jan 2023, 20:20